1
Gene Therapy for Wiskott-Aldrich Syndrome
Condition(s):Wiskott-Aldrich Syndrome (WAS)Last Updated:February 25, 2021Active, not recruiting
Wiskott-Aldrich Syndrome: 272 Clinical Trials, Page 1 of 28
Hide Studies Not Open or Pending
2
Haploidentical Hematopoietic Stem Cell Transplantation Patients With Wiskott-Aldrich Syndrome
Condition(s):Wiskott-Aldrich SyndromeLast Updated:April 26, 2017Completed
3
Study of Reduced Toxicity Myeloablative Conditioning Regimen for Wiskott-Aldrich Syndrome (WAS)
Condition(s):Wiskott-Aldrich SyndromeLast Updated:July 14, 2014Completed
4
Patients Treated for Wiskott-Aldrich Syndrome (WAS) Since 1990
Condition(s):Wiskott-Aldrich SyndromeLast Updated:August 10, 2020Completed
5
Romiplostim Treatment for Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome.
Condition(s):Wiskott-Aldrich SyndromeLast Updated:December 28, 2020Completed
6
Gene Therapy for Wiskott-Aldrich Syndrome (WAS)
Condition(s):Wiskott-Aldrich SyndromeLast Updated:November 21, 2019Completed
7
Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome
Condition(s):Wiskott-Aldrich SyndromeLast Updated:May 6, 2020Recruiting
8
Post-transplant Cyclophosphamide in Wiskott-Aldrich Syndrome
Condition(s):Wiskott-Aldrich SyndromeLast Updated:June 27, 2017Unknown status
9
A Clinical Study to Evaluate the Use of a Cryopreserved Formulation of OTL-103 in Subjects With Wiskott-Aldrich Syndrome
Condition(s):Wiskott-Aldrich SyndromeLast Updated:December 8, 2020Active, not recruiting
10
Long Term Safety Follow up of Haematopoietic Stem Cell Gene Therapy for the Wiskott Aldrich Syndrome
Condition(s):Wiskott-Aldrich SyndromeLast Updated:August 21, 2019Recruiting